Effect of an Oral Acerola Juice Powder on Skin Beauty Parameters in Women Exposed to Environmental Stresses

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-03

Study Completion Date

2026-02-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is being conducted to evaluate the efficacy and the safety of an oral acerola-based product on skin ageing parameters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Biological Effects of a Polyphenol Supplement

NCT05829382

Healthy Aging

COMPLETED NA

To Determine the Activity and Mechanisms of Cranberries to Attenuate Skin Photoaging and Improve Skin Health in Women

NCT04183920

Skin Health

COMPLETED NA

The Effect of Green Tea and Vitamin C on Skin Health

NCT01032031

Skin Cancer

COMPLETED NA

A Study to Evaluate Pharmacokinetics of C3G and to Estimate Antioxidative Markers After Repeated Administration of Mulberry Fruit Extract

NCT01230268

Oxidative Stress

COMPLETED NA

Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk

NCT00574574

Cardiovascular Disease Skin Health Postmenopause

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective of this study is to assess efficacy of the product on skin translucency after 84 days of product compared to a placebo. The study will also evaluate the effect of the product on different skin parameters (radiance, firmness, elasticity, skin barrier function, skin pH, blood flow) with different instruments. The quality of life and the improvement of skin properties will also be collected with questionnaires completed by the subjects. Finally, the safety of this product will be assessed by collecting all adverse events that might occur during the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pollution; Exposure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Double-blind, randomised, placebo-controlled study

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acerola Juice Powder 1200 mg/day

Higher dose

Group Type EXPERIMENTAL

Acerola Juice Powder 1200 mg/day

Intervention Type DIETARY_SUPPLEMENT

4 capsules per day, each capsule containing 300mg of Acerola and 100 mg of maltodextrin

Acerola Juice Powder 600 mg/day

Lower dose

Group Type EXPERIMENTAL

Acerola Juice Powder 600 mg/day

Intervention Type DIETARY_SUPPLEMENT

4 capsules/day, each capsule containing 150 mg of Acerola and 250 mg of Maltodextrin

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

4 capsules per day, each capsule containing 400 mg of maltodextrin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acerola Juice Powder 1200 mg/day

4 capsules per day, each capsule containing 300mg of Acerola and 100 mg of maltodextrin

Intervention Type DIETARY_SUPPLEMENT

Acerola Juice Powder 600 mg/day

4 capsules/day, each capsule containing 150 mg of Acerola and 250 mg of Maltodextrin

Intervention Type DIETARY_SUPPLEMENT

Placebo

4 capsules per day, each capsule containing 400 mg of maltodextrin

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy women.
2. Chinese.
3. Age: in each group of products

* 50% of subject having 30 to 45 years old
* 50% of subject having 46 to 60 years old
4. Phototype: II to IV.
5. Subject with dull skin from grade 3 to 7 on skin dullness 9 points scale.
6. Subject exposed to high air pollution up to 2 to 3 hours per day (traffic roads, cigarette smoke, dusts or small particles).
7. Subject who accepts daily exposition to blue light (mobile phone, Ipad, laptop or get exposure to LED light) at home (at least 2h).
8. Subject with at least 1 spot on the face.
9. Subject with BMI ≤ 30
10. Subject, psychologically able to understand the study related information and to give a written informed consent.
11. Subject having given freely and expressly her informed consent.
12. Subject agreeing to not change her alimentary and cosmetic habits on the studied area during the study.

Exclusion Criteria

In term of population :

1. Pregnant or nursing woman or planning a pregnancy during the study.
2. Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
3. Minor subject.
4. Major subject who is under guardianship or who is not able to express her consent.
5. Subject in a social or sanitary establishment.
6. Subject suspected to be non-compliant according to the investigator's judgment.

In term of associated pathology :
7. Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk.
8. Subject suffering from a severe or progressive disease.
9. Subject with known history of or suffering from skin disease that may interfere with evaluation of the study results and/or subject safety.
10. Subject having history of severe allergy or anaphylactic shock including known risk of hypersensitivity to one of the components of the composition of the product

Related to previous or ongoing treatment :
11. Subject undergoing a topical treatment on the test area or a systemic treatment:

* anti-inflammatory medication and/or anti-histamines during the previous 2 weeks and during the study;
* corticosteroids during the 2 previous weeks and during the study;
* retinoids and/or immunosuppressors during the 3 previous months and during the study;
* any medication stabilized for less than one month.
12. Subject having started or changed her oral contraceptive or any other hormonal treatment during the three previous months.
13. Subject having done facial skin care like peeling, mask… during the previous 2 weeks and during the study.
14. Subject having used oral nutritional supplements and/or vitamin supplementation during the previous month and during the study

In term of lifestyle :
15. Intensive exposure to sunlight or UV-rays within the previous month and/or foreseen during the study;
16. Subject having used topical products containing actives substances during the previous 2 weeks and during the study
17. Subject planning to change her life habits during the study.
18. Subject with unstable eating habits or planning to change them during the study
19. Subject with an excessive consumption of alcohol (more than 2 glasses of wine per day) and/or tobacco (more than 5 cigarettes per day).

Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No